Results of a Remotely Delivered Hypertension, Lipid Program Across a Diverse Health Care Network

JAMA Cardiology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 9, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.4018?guestAccessKey=0ca9cc74-23c4-44db-b1d5-38e3583d5461&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110922

 

About The Study: The results of this study that included more than 10,000 patients with blood pressure and/or cholesterol levels above guideline-recommended targets indicate that a standardized remote blood pressure and cholesterol management program may help optimize guideline-directed therapy at scale, reduce cardiovascular risk, and minimize the need for in-person visits among diverse populations. 

Authors: Benjamin M. Scirica, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jamacardio.2022.4018)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.